Hemostatic defects induced by cardiopulmonary bypass.
D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000209:etiology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006400:Hematocrit; D006470:Hemorrhage / Q000097:blood / Q000209:etiology*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D010958:Plasminogen / Q000378:metabolism; D011479:Protamines / Q000008:administration & dosage; D013925:Thromboplastin; D013997:Time Factors
D005338:Fibrin Fibrinogen Degradation Products; D011479:Protamines; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D013925:Thromboplastin